Note: Ingredients listed on restricted chemical lists
EC/CAS
69-65-8
Name of the chemical
D-mannitol C6H14O6
Concentration
N/A
General Information
Revision date
2013-07-19
Product name
Phentolamine Mesylate Injection, 0.235 mg/mL
1.2.1 Relevant identified uses
Adrenergic blocker used to reverse the effects of local anesthesia
Emergency telephone
1-519-623-4800 (Monday-Friday 08 30 to 16 30
Icons in SDS
Company Information
company name
henry schein
Section 2
2.1 Classification of the substance or mixture
Not classifiable according to GHS
2.2 Label elements
Symbol None
Hazard statements
May cause skin and/or eye irritation Can cause central nervous system effects such as dizziness and weakness. Stimulates the gastrointestinal tract, potentially resulting in gastric secretion, nausea, vomiting, diarrhea. Acts as a depressant (by vasodilation) on the cardiovascular system, with potential effects including hypotension (lowering of blood pressure), tachycardia (abnormal heart rhythm). Avoid exposure to individuals with hypersensitivity to phentolamine. CONSULT PRODUCT INSERT FOR CLINICAL AND PHARMACOPIAL INFORMATION Signs and Symptoms of Overexposure: Drop in blood pressure, tachycardia, cardiac stimulation, dizziness, excitability, headache.
Response
P312 – Call a POISON CENTER or doctor/physician if you feel unwell
Disposal
P501 – Dispose of contents/container in accordance with local/provincial/federal regulations WHMIS Regulatory Status: Not WHMIS-Controlled
